Drug-resistant tuberculosis (DR-TB), including multidrug-resistant TB (MDR-TB) and
extensively drug-resistant TB (XDR-TB), is considered a potential obstacle for elimination of …

Multidrug-resistant and extensively drug-resistant tuberculo... : Current Opinion in Infectious
Diseases Multidrug-resistant and extensively drug-resistant tuberculosis: consequences for the …

SETTING: Multidrug-resistant tuberculosis (MDR-TB) and the human immunodeficiency
virus (HIV) pose two of the greatest threats to global tuberculosis (TB) control. Given …

The emergence of extensively drug-resistant tuberculosis (XDR-TB) poses a significant
public health threat for human immunodeficiency virus (HIV) programmes and tuberculosis …

Abstract Background. Multidrug-resistant (MDR) tuberculosis (TB) has emerged as a global
epidemic, with∼ 425,000 new cases estimated to occur annually. The global human …

Background Multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis
(TB) have emerged in high-HIV-prevalence settings, which generally lack laboratory …

Resistance to anti‐tuberculosis (TB) drugs continues to present a major challenge to global
public health. Resistance usually develops due to inadequate TB management, including …

Drug-resistant tuberculosis (TB) is emerging as a major clinical and public health challenge
in areas of sub-Saharan Africa where there is a high prevalence of human …

Rationale: The multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis
(TB) epidemics are rapidly expanding in South Africa. Our initial report of HIV-associated …

Tuberculosis (TB) is a major cause of morbidity and mortality worldwide. Each year, there
are eight million new Mycobacterium tuberculosis complex (MTB) infections and three …